Active ingredientNifekalantCat. No. P-N056-001CAS 130636-43-0Family · Pharmaceutical analytical standards
Nifekalant
A class III antiarrhythmic that blocks potassium channels and prolongs cardiac repolarisation; approved in Japan in 1999, it is given intravenously against ventricular tachyarrhythmias. This family brings together the active ingredient and labelled standards.
Did you know?It was developed in Japan and is a 'pure' potassium channel blocker that does not act on sodium or calcium channels; its uses include the resuscitation of patients in cardiac arrest.
Go to the active ingredient →Active ingredientNifekalantCat. No. P-N056-001CAS 130636-43-0
Active ingredientNifekalant HClCat. No. P-N056-002CAS 130656-51-8
Isotopically labelledNifekalant-d4Cat. No. P-N056-003No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.